Aethlon for HIV and Hepatitis-C trials in India

By SiliconIndia   |   Tuesday, 29 March 2005, 08:00 Hrs
Printer Print Email Email
SAN DIEGO: Aethlon Medical, Inc. announced today that it has received Indian government nod for their upcoming HIV and Hepatitis-C trials.

Sandeep Malik, President of Qualtran, said "we are pleased to disclose that Aethlon has received letters of support from both the Government of India and the Confederation of Indian Industry (CII), which is India's premier business association." Malik continued, "Members of Parliament, Ashok Argal and Shripad Naik are personally supportive of Aethlon's HIV trials in India. They believe that if successful, Aethlon's technology could have a profound impact on the condition of HIV patients in India and around the world."

Malik concluded, "HIV infections in India could increase sharply if effective treatment strategies are not widely implemented. This could have devastating effects on the country's economic and social systems. Aethlon's Hemopurifier technology and forthcoming trials have been very well received by key opinion leaders in India."

According to the Gates Foundation, 5.1 million individuals in India were infected with HIV in 2004, a ten-fold increase over the last decade. It is projected that the number of HIV-infected citizens in India could increase to 20-25 million by 2010. Aethlon stated that site selection for the trials is under way, and that patient enrollment should begin in the coming months.


SPOTLIGHT
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..